CEO Andrew Morton on BLMH's profitable Fiscal Q3 2022 which had revenues of $8.4M:
https://www.youtube.com/watch?v=Kgo7HXrK9j8&ab_channel=Proactive
Morton emphasizes that, while a large part of BLMH's initial business was covid testing, the company wasn't launched because of the pandemic but because the pandemic exposed long-term gaps in our health care systems that BLMH is aiming to fill.
ICYMI: For the three months ended June 30, 2022, BLMH's unaudited Fiscal Q3 revenues of $8.4M bring YTD revenue to $24.9M!
- Adjusted EBITDA: $1.4M
- Cash on hand: $5.9M with receivables of $6.8M
- Revenue guidance for full fiscal year: $25-28M
- Extended contract with State of Texas K-12 Schools for additional year